|
1.Shi HF, Shao H*, Sun MY, Zhou X, Chen R, Xu XH. Outcome analysis on the rotation practice course for the professional degree graduates of clinical
pharmacy at Peking University. Journal of Chinese Pharmaceutical Sciences 2016; 25 (2):140–144.
2.王一珂, 马旭, 焦园园, 邵宏*, 张艳华. 药物基因组学个体化用药证据基础分析与评价. 中国药房2016; 27(8):1009-1012.
3.Hu Q, Tang HL*, Shao H*. Incretin-based therapies for type 2 diabetes with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Journal of Chinese Pharmaceutical Sciences 2016; 25(3):206-214.
4.Zhou X, Wang X, Song Q, Yang H, Zhu X, Yu J, Song G, Di L, Ren J*, Shao H*, Lyerly HK. Transformation of alkylating regimen of thiotepa into
tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage
chemotherapy. International Journal of Clinical Pharmacology and Therapeutics 2015; 53(November):914-922.
5.付超, 邵宏*, 史慧峰, 李喜西, 史录文. 临床药师考试主成分分析及实践能力相关性研究. 中国新药杂志2014; 23(14):1712-1716
6.杨辉, 邵宏*, 赵紫楠, 史慧峰, 胡琴. SSRI类抗抑郁药物遗传学文献计量分析. 中国新药杂志2014; 23(9):983-988.
7.魏艳红, 邵宏*. 国外临床药师认证体系及对我国的启示. 中国新药杂志2013; 22(21):2574-2578
8.王宁, 邵宏*, 付超, 杨辉, 赵紫楠, 李丹丹. 临床药师知识体系建立与专业学位硕士研究生课程设置优化研究. 中国新药杂志2013; 22(6):728-732.
9.周心娜, 董宁宁, 余靖, 王小利, 任军* , 邵宏*. CYP3A5 和GSTP1 基因多态性与多西他赛联合塞替派治疗转移性乳腺癌近期疗效的相关性研究.
中国药学杂志2012; 47(2):127-131.
10.Bao NJ, Shao H*, Nie XY, Wu YP, Yan Q, Li XX, Yang W, Wang N, Zheng K, Wei YH, Shi LW. Analysis of the status of clinical pharmacist pilot
training in Chinese hospitals. Journal of Chinese Pharmaceutical Sciences 2011; 20(4):410-414.
|
